The purpose of the study is to understand the origins of differential response to beta-blockers in African-Americans and may provide insight regarding racial differences in cardiovascular risk.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Plasma BNP After 6-weeks of Beta-Blocker
Timeframe: 6 weeks
Change in Plasma NT-proBNP After 6-weeks of Beta-Blocker
Timeframe: 6 weeks
Change in Plasma MR-proANP After 6-weeks of Beta-Blocker
Timeframe: 6 weeks